Appili Therapeutics
Manufacturing · Canada · 1-10 Employees
View Company Info for Free
Overview
Headquarters
1344 Summer St 21, Halifax, Nova Scotia,...Phone Number
(902) 442-4655Website
www.appilitherapeutics.comRevenue
<$5 MillionStock Symbol
APLIIndustry
About Appili Therapeutics
Appili Therapeutics is a biopharmaceutical company dedicated to addressing global challenges in infectious diseases and biodefense. The company focuses on innovative drug development programs aimed at meeting unmet patient needs across a variety of infectious diseases. Their product pipeline includes a novel oral suspension for serious infections, a potential vaccine for tularemia, and a topical treatment for skin infections. Appili Therapeutics actively seeks partnerships to enhance clinical programs and accelerate the commercialization of their solutions.Explore more
Appili Therapeutics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Appili Therapeutics
Compare insights from companies similar to Appili Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Appili Therapeutics Tech Stack
A closer look at the technologies used by Appili Therapeutics
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding Appili Therapeutics
Sign Up For FreeTo access detailed company insights
Appili Therapeutics is a biopharmaceutical company dedicated to addressing global challenges in infectious diseases and biodefense. The company focuses on innovative drug development programs aimed at meeting unmet patient needs across a variety of infectious diseases. Their product pipeline includes a novel oral suspension for serious infections,... Read More
